Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page revision label changed from v3.6.0 to v3.6.2, indicating a new build of the page; no study content differences are evident.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status updated to no longer enroll; new help/navigation sections added and the Intervention/Treatment header updated, along with a new revision label.SummaryDifference0.4%

- Check27 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, updating the site's revision/build identifier. This change represents a metadata version update and does not alter the page content or layout.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision from v3.5.3 to v3.5.4 on the page indicates a minor platform/update change. It reflects an underlying system or interface update rather than any modification to the study details or eligibility information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s footer “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change rather than new or changed study information.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.